New Delhi: Hyderabad based drug major, Dr Reddy’s has recently launched Tadalafil tablets in the US market. The drug launched is used to treat erectile dysfunction, also known as impotence.
Dr Reddy’s Laboratories on Tuesday said it has launched Tadalafil tablets, used to treat erectile dysfunction, in the US market. Tadalafil tablets are a therapeutic equivalent generic version of Adcirca tablets, Dr Reddy’s Laboratories said in a BSE filing.
Tadalafil is used to treat the symptoms of two conditions found in men: benign prostatic hyperplasia (BPH) and erectile dysfunction (ED). Tadalafil is also used to treat pulmonary arterial hypertension (PAH).
Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image. A physical cause can be identified in about 80% of cases. These include cardiovascular disease, diabetes mellitus, neurological problems such as following prostatectomy, hypogonadism, and drug side effect.
Also Read: Lupin gets USFDA tentative approval for generic tablets to treat Erectile Dysfunction
Quoting IMS Health data, Dr Reddy’s Laboratories said, the Adcirca brand and generic had US sales of approximately USD 490 million for the most recent twelve months ending in November 2018.
Dr Reddy’s Lab was founded by Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited, of Hyderabad.
Dr Reddy’s manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology products.
Also Read: Unichem Labs gets tentative USFDA nod for erectile dysfunction treatment tablets
